| Literature DB >> 30603518 |
Dongkyu Kim1, Gun-Sik Cho1, Choongseong Han1,2, Dong-Hyuk Park3, Hee-Kyung Park2, Dong-Hun Woo1, Jong-Hoon Kim4.
Abstract
Liver failure is one of the main risks of death worldwide, and it originates from repetitive injuries and inflammations of liver tissues, which finally leads to the liver cirrhosis or cancer. Currently, liver transplantation is the only effective treatment for the liver diseases although it has a limitation due to donor scarcity. Alternatively, cell therapy to regenerate and reconstruct the damaged liver has been suggested to overcome the current limitation of liver disease cures. Several transplantable cell types could be utilized for recovering liver functions in injured liver, including bone marrow cells, mesenchymal stem cells, hematopoietic stem cells, macrophages, and stem cell-derived hepatocytes. Furthermore, paracrine effects of transplanted cells have been suggested as a new paradigm for liver disease cures, and this application would be a new strategy to cure liver failures. Therefore, here we reviewed the current status and challenges of therapy using stem cells for liver disease treatments.Entities:
Keywords: Liver failure; Liver regeneration; Secretome; Stem cell transplantation
Year: 2017 PMID: 30603518 PMCID: PMC6171672 DOI: 10.1007/s13770-017-0093-7
Source DB: PubMed Journal: Tissue Eng Regen Med ISSN: 1738-2696 Impact factor: 4.169